Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk

Public Health Nutrition

Volumn 2, Issue 3, 1999, Pages 283-291

  Janowsky, Esther C ^a   Lester, Gayle E ^b   Weinberg, Clarice R ^c   Millikan, Robert C ^a   Schildkraut, Joellen M ^d   Garrett, Peter A ^a   Hulka, Barbara S ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1,25 dihydroxyvitamin D; Breast cancer epidemiology; Vitamin D

Indexed keywords

CALCITRIOL;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 0032832978     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1368980099000385     Document Type: Article

References (48)

1. DeLuca HF, Ostrem V. The relationship between the vitamin D system and cancer. Adv. Exp. Med. Biol. 1987; 206: 413-29.
2. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 1989; 320: 980-91.
3. Manoglas SC. Vitamin D and its relevance to cancer. AntiCancer Res. 1987; 7: 625-38.
4. Studzinski GP, Moore DC. Sunlight - can it prevent as well as cause cancer? Cancer Res. 1995; 55: 4014-22.
5. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int. J. Epidemiol. 1990; 19: 820-4.
6. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med. 1990; 19: 614-22.
7. Blot WJ, Fraumeni JF, Stone BJ. Geographic patterns of breast cancer in the United States. J. Natl. Cancer Inst. 1977; 59: 1407-11.
8. Simard A, Vobecky J, Vobecky JS. Vitamin D deficiency and cancer of the breast: an unprovocative ecological hypothesis. Can. J. Public Health 1991; 82: 300-3.
9. Chouvet C, Vicard E, Devonec M, Saez S. 1,25-dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem. 1986; 24: 373-6.
10. Frappart L, Falette N, Lefebvre MF, Bremond A, Vauzelle JL, Saez S. In vitro studies of effects of 1,25-dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT-20. Differentiation 1989; 40: 63-9.
11. Welsh J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem. Cell Biol. 1994; 72: 537-47.
12. James SY, Mackay AG, Colston KW. Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J. Mol. Endocrinol. 1995; 14: 391-4.
13. Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984; 224(4656): 1438-40.
14. Reinhardt TA, Ramberg CF, Horst RL. Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3,1,25-dihydroxyvitamin D2, and its 24 epimer. Arch. Biochem. Biophys. 1989; 273: 64-71.
15. Nemere I, Yoshimoto Y, Norman AW. Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology 1984; 115: 1476-83.
16. Krishnan AV, Feldman D. Stimulation of 1,25-dihydroxyvitamin D3 receptor gene expression in cultured cells by serum and growth factors. J. Bone Miner. Res. 1991; 6: 1099-107.
17. Love RR, Mazess RB, Barden HS, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N. Engl. J. Med. 1992; 326: 852-6.
18. Holick MF. The use and interpretation of assays for vitamin D and its metabolites. J. Nutr. 1990; 120: 1464-9.
19. Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA, Bundred NJ. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer with bone metastases. J. Clin. Endocrinol. Metab. 1997; 82: 118-22.
20. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J. Natl. Cancer Inst. 1994; 86: 705-12.
21. Abrams SA, O'Brien KO, Liang LK, Stuff JE. Differences in calcium absorption and kinetics between black and white girls aged 5-16 years. J. Bone Miner. Res. 1995; 10: 829-33.
22. Meier DE, Luckey MM, Wallenstein S, Clemens TL, Orwoll ES, Waslien CI. Calcium, vitamin D, and parathyroid hormone status in young white and black women: association with racial differences in bone mass. J. Clin. Endocrinol. Metab. 1991; 72: 703-10.
23. M'Buyamba-Kabangu JR, Fagard R, Lijnen P, Bouillon R, Lissens W, Amery A. Calcium, vitamin D-endocrine system, and parathyroid hormone in black and white males. Calcif. Tissue Int. 1987; 41: 70-4.
24. Reasner CA, Dunn JF, Fetchik DA, et al. Alteration of vitamin D metabolism in Mexican-Americans. J. Bone Miner. Res. 1990; 5: 13-17.
25. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J. Clin. Invest. 1985; 76: 470-3.
26. Loomis F. Skin-pigment regulation of vitamin D biosynthesis in man. Science 1967; 157: 501-6.
27. Hiatt RA, Krieger N, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N. Prediagnostic serum vitamin D and breast cancer. J. Natl. Cancer Inst. 1998; 90: 461-3.
28. Garrett PA, Hulka BS, Kim YL, Farber RA. HRAS protooncogene polymorphism and breast cancer. Cancer Epidemiol. Biomark. Prev. 1993; 2: 131-8.
29. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
30. SAS Companion for the Microsoft Windows Environment, version 6. Cary, NC: SAS Institute Inc., 1993.
31. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. I. The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer, 1980.
32. Harris JR, Lippman ME, Veronesi U, Willet W. Breast cancer. N. Engl. J. Med. 1992; 327: 319-28.
33. Bouillon RA, Auwerx JH, Lissens WD, Pelemens WK. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-hydroxyvitamin cholecalciferol deficiency. Am. J. Clin. Nutr. 1987; 45: 755-63.
34. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J. Clin. Endocrinol. Metab. 1990; 71: 405-13.
35. Cantatore FP, Carrozzo M, Magle DM, D'Amore M, Pipitone V. Serum 1,25(OH)2D in the elderly and osteoporotic subjects from southern Italy. In: Norman AW, Schafer K, Grigoleit H-G, Herrath DV, eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Proceedings of the Seventh Workshop on Vitamin D. New York: Walter de Gruyter & Co., 1988; 897-8.
36. Halloran BP, Portale AA, Lonergan ET, Morris RC Jr. Production and metabolic clearance of 1,25-dihydroxyvitamin D in men: effect of advancing age. J. Clin. Endocrinol. Metab. 1990; 70: 318-23.
37. Tsai KS, Wahner HW, Offord KP, Melton LJ III, Kumar R, Riggs BL. Effect of aging on vitamin D stores and bone density in women. Calcif. Tissue Int. 1987; 40: 241-3.
38. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995; 274: 1683-6.
39. 3 concentration regulated by dietary calcium? In: Norman AW, Schafer K, Grigoleit H-G, Herrath DV, eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Proceedings of the Seventh Workshop on Vitamin D. New York: Walter de Gruyter & Co., 1988; 662-3.
40. Weiss NS, Liff JM. Accounting for the multicausal nature of disease in the design and analysis of epidemiologic studies. Am. J. Epidemiol. 1983; 117: 14-18.
41. Webb R, Pilbeam C, Hanafin N, Holick M. An evaluation of the relative contribution of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am. J. Clin. Nutr. 1990; 51: 1075-81.
42. Tsai KS, Heath H III, Kumar R, Riggs BL. Impaired vitamin D metabolism with aging in women. J. Clin. Invest. 1984; 73: 1668-72.
43. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cell proliferation. Lancet 1989: i: 188-91.
44. Lieberman UA. Inborn errors in vitamin D metabolism -their contributions to the understanding of vitamin D metabolism. In: Norman AW, Schafer K, Grigoleit H-G, Herrath DV, eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Proceedings of the Seventh Workshop on Vitamin D. New York: Walter de Gruyter & Co., 1988; 935-47.
45. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996; 56: 4108-10.
46. Ikekawa N. Structures and biological activities of vitamin D metabolites and their analog. Med. Res. Rev. 1987; 7: 333-66.
47. Matsumoto T. Cell differentiation and vitamin D. Nippon Naibunpi Gakki Zasshi 1992; 68(5): 526-37.
48. Mehta RG, Moriarty RM, Mehta RR, et al. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, la-hydroxyvitamin D5. J. Natl. Cancer. Inst. 1997; 89: 212-18.